OTCMKTS:NMRD Nemaura Medical (NMRD) Stock Price, News & Analysis $0.0001 0.00 (0.00%) As of 11/9/2026 02:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About Nemaura Medical Stock (OTCMKTS:NMRD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nemaura Medical alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000550-Day Range N/A52-Week Range$0.00▼$0.05Volume12,515 shsAverage Volume600 shsMarket Capitalization$4.04 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nemaura Medical, Inc. is a medical technology company focused on developing wearable solutions for diabetes and metabolic health monitoring. Its principal product is SugarBEAT, a non-invasive glucose monitoring system designed to provide continuous or periodic glucose readings without the need for traditional finger-stick testing. SugarBEAT is designed to use a disposable skin patch, a reusable sensor transmitter and a software application to collect and display glucose information. The company has also described applications for the technology in diabetes management, prediabetes monitoring and broader wellness programs. Nemaura Medical has pursued regulatory clearances and commercial opportunities in international markets, including the United Kingdom and Europe. The company is headquartered in Fremont, California. Public information about its current commercial operations, product availability and leadership may be limited, and the regulatory status of its products can vary by geography.AI Generated. May Contain Errors. Read More Receive NMRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMRD Stock News HeadlinesNMRD Nemaura Medical Inc.June 18, 2025 | seekingalpha.comNemaura Medical (OTC:NMRD) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.November 10 at 1:00 AM | Weiss Ratings (Ad)Nemaura Medical Inc (NMRD)May 26, 2024 | investing.comNXNN Nexeon Medsystems IncMay 24, 2024 | seekingalpha.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 22, 2024 | finance.yahoo.comNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finanznachrichten.deImportant Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finance.yahoo.comSee More Headlines NMRD Stock Analysis - Frequently Asked Questions How have NMRD shares performed this year? Nemaura Medical's stock was trading at $0.0001 at the beginning of 2026. Since then, NMRD stock has increased by 0.0% and is now trading at $0.0001. How were Nemaura Medical's earnings last quarter? Nemaura Medical Inc. (OTCMKTS:NMRD) issued its earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter. How do I buy shares of Nemaura Medical? Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nemaura Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), NVIDIA (NVDA), Palantir Technologies (PLTR), Citius Pharmaceuticals (CTXR), iBio (IBIO), Jaguar Animal Health (JAGX) and Aeva Technologies (AEVA). Company Calendar Today11/09/2026Next Earnings (Estimated)11/17/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:NMRD CIK1602078 Webnemauramedical.com Phone(646) 416-8000FaxN/AEmployees40Year Founded2011Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.02 thousand Price / Sales1.34 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares40,352,000Free Float24,042,000Market Cap$4.04 thousand OptionableNo Data Beta0.38 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:NMRD) was last updated on 11/9/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWe flagged Marvell at $80. It's up 251%.On Feb. 7, 2026, Street Sheet Research members saw Marvell (NASDAQ: MRVL) at $80.28, with a $118 target from N...The Street Sheet | SponsoredIntel Shares Jumped 177% After Elon Musk's DealElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
